ArticleBritish journal of pharmacology2012

A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis.

J Kankanala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.